期刊文献+

通心络对高血压病患者血脂水平及颈动脉硬化的影响 被引量:2

Effect of tongxinluo on blood lipid and carotid atherosclerosis in patients with hypertension
在线阅读 下载PDF
导出
摘要 目的 :探讨通心络对高血压病患者血脂水平和颈动脉硬化的影响。方法 :110例高血压病合并颈动脉硬化的患者随机分为治疗组和对照组。均在抗高血压的治疗基础上 ,治疗组给予通心络 ,对照组给予复方丹参片。在治疗的前1天及服药后3月 ,6月进行血脂和颈动脉彩色超声多普勒检查。观察对比两组的血脂水平和颈动脉内、中膜增生、内径变化情况。结果 :治疗组3个月后TC、TG均有不同程度的下降 ,HDLC有轻度增高 ,6个月后 ,TC、TG与治疗前和对照组比较差异有显著性。同样治疗6个月后 ,治疗组颈动脉IMT、管腔内径有明显变化 ,和治疗前及对照组比较差异有显著性。结果 :合并高血脂的高血压患者 ,给予通心络药物治疗 ,可有效的防止或延缓颈动脉硬化的发展 。 Objective:To discuss the curative effect and protection of tongxinluo on blood lipid and carotid atherosclerosis in patients with hypertension.Methods:110essential hypertension patients with carotid atherosclerosis and hyperlipaemia were randomly divided into treatment group and control group.The treatment group were treated with tongxinluo and Their carotid and lipid levels were checked after3and6months,in order to compare with the control group on the lipid levels,carotid inner diameters,the thickness between carotid intima-media thickness(IMT).Results:After3months of treatment tongxinluo could efficiently decrease total cholesterol(TC),triglyceride(TG),lowdensity lipoprotein cholesterol(LDLC)level in plasme,and as the treatment prolonged,the decrease of the dinilution of IMT all had statistcal signifiˉcance.Conclusion:Tongxinluo can efficienly decrease the lipid level in plasma,it can improve and stabilize the carotid atherosclerosis.
作者 严华
出处 《现代医药卫生》 2005年第6期632-633,共2页 Journal of Modern Medicine & Health
关键词 通心络 颈动脉硬化 治疗组 血脂水平 对照组 高血压病 患者 合并 影响 发展 Altherosclerosis Serum Lipids Tongxinluo
  • 相关文献

参考文献9

二级参考文献25

  • 1赵明中,高承梅,张宇洋.通心络胶囊对实验性心肌缺血再灌注损伤保护作用的实验研究[J].中国中医基础医学杂志,2000,6(1):36-38. 被引量:50
  • 2[1]KINLAY S,GANZ P.Role of endothelial dysfunction in coronary artery disease and implications for therapy[J].Am J Cardiol,1997,80(9A):11I-16I.
  • 3[2]CELERMAJER D S,SORENSEN K E,GOOCH V M,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340(8828):1111-1115.
  • 4[3]SUWAIDI J A,HAMASAKI S,HIGANO S T,et al.Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction[J].Circulation,2000,101(9):948-954.
  • 5[4]JADHAV U M,SIVAARAMAKRISHAN A,KADAM N N.Noninvasive assessment of endothelial dysfunction by brachial artery flow-mediatation in prediction of coronary artery disease in Indian subjects[J].Indian Heart J,2003,55(1):44-48
  • 6[5]MONROE V S,KERENSKY R A,RIVERA E,et al.Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes[J].J Am Coll Cardiol,2003,41(4 suppl):23s-30s.
  • 7[6]KINLAY S,SELWYN A P.Effects of statines on inflammation in patients with acute and chronic coronary syndromes[J].Am J Cardiol,2003,91(4A):9B-13B.
  • 8[7]BELL D M,JOHNS T E,Lopezlm.Endothelial dysfunction :implication for therapy of cardiovascular diseases [J].Ann Pharmacother,1998,32(4):459-470.
  • 9[9]PIATTI P,FRAGASSO G,MONTI L D,et al.Acute intravenous L-arginine infusion degreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms:correlation with asymmetric dimethylarginine levels[J].Circulation,2003,107(3):429-436.
  • 10Wong M,rteriosclerosis,1993年,13卷,482页

共引文献3183

同被引文献64

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部